房室结消融联合起搏治疗的永久性房颤患者生存质量的SF-36测评

目的：探讨中文版SF-36健康调查问卷在房室结消融联合起搏（ABL＋PM）治疗永久性房颤患者后生存质量评估中的作用.方法：采用中文版简明健康调查问卷SF-36对19名永久性房颤患者治疗前及治疗后6个月进行问卷调查,评估患者生存质量.同时治疗前后分别行心脏超声检测患者心功能.量表采用标准分法进行评分、统计分析.结果：治疗前后比较,永久性房颤患者经ALB＋PM治疗后,患者心功能及SF-36量表各项指标除躯体疼痛（P＞0.05）外,均与治疗前相比较明显改善（P＜0.01）.生存质量总分值与心功能各项线性回归分析结果表明：生存质量总分值与心功能各项均有相关性.结论：ABL＋PM是治疗永久性房颤的有效方法,中文版简明健康调查问卷SF-36可以作为评定该方法治疗永久性房颤患者生存质量的一个重要指标.

Evaluation on the quality of life of permanent atrial fibrillation patients treated by AV node ablation and pacemaker implantation with SF-36

Objective:To evaluate the effectiveness of AV node ablation and pacemaker implantation(ABL+PM) on the quality of life in the patients with permanent atrial fibrillation(AF). Method:The cardiac function was measured in 19 patients with permanent AF diagnosed by conventional 2-Dimensional echocardiography. The quality of life between baseline and after 6 months treatments was observed according to SF-36(Chinese edition). The data were compared by the t-test of pair-matching materials. Result:Both cardiac function and quality of life were significantly improved after 6 months treatments(P<0.01) compared with the baseline indexes. Conclusion: ABL+PM is an effect treatment to patients with permanent AF,and the SF-36 (Chinese edition) plays an important role in evaluating the effectiveness of ABL+PM and the quality of life in AF patients.